NCT06027164View on ClinicalTrials.gov

Kosmos Trio and Ejection Fraction Pivotal Study

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

August 31, 2023

Study Completion Date

May 16, 2024

Conditions
Cardiac Disease
Interventions
DEVICE

Portable Ultrasound System

EchoNous KOSMOS

Trial Locations (1)

48126

Revival Research Institute LLC, Dearborn

Sponsors

Lead Sponsor

EchoNous Inc.

Collaborators (1)

Centaur Labs
All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

collaborator

Revival Research Institute LLC

UNKNOWN

collaborator

Centaur Labs

UNKNOWN

lead

EchoNous Inc.

INDUSTRY

NCT06027164 - Kosmos Trio and Ejection Fraction Pivotal Study | Biotech Hunter | Biotech Hunter